Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3382783 | 0.78 | — | — | |
| SCHEMBL3383577 | 0.74 | MEN1 (0.34) | — | |
| SCHEMBL3386635 | 0.74 | MEN1 (0.34) | — | |
| SCHEMBL3385698 | 0.69 | CHRM2 (0.33) | CHRM2CHRM1CHRM3 | |
| SCHEMBL9410009 | 0.68 | CHRM2 (0.41) | CHRM2CHRM1CHRM3 | |
| SCHEMBL14764516 | 0.68 | CHRM2 (0.41) | CHRM2CHRM1CHRM3 | |
| SCHEMBL13157267 | 0.67 | CHRM2 (0.37) | CHRM2CHRM1CHRM3 | |
| SCHEMBL1079861 | 0.67 | CHRM2 (0.37) | CHRM2CHRM1CHRM3 | |
| SCHEMBL212033 | 0.66 | CHRM2 (0.42) | CHRM2CHRM1CHRM3 | |
| SCHEMBL8509594 | 0.66 | HPGD (0.39) | CHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651649-B1 | NOVEL CYANOPYRROLIDIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICATION | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-1651649-A1 | NOVEL CYANOPYRROLIDIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005012308-A1 | NOVEL CYANOPYRROLIDIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-02-10 | — | — | WO | disclosed |